- Home
- ALKS vs AB Comparison
ALKS vs AB Comparison
Compare ALKS & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALKS
- AB
- Stock Information
- Founded
- ALKS 1987
- AB 1987
- Country
- ALKS Ireland
- AB United States
- Employees
- ALKS N/A
- AB N/A
- Industry
- ALKS Biotechnology: Pharmaceutical Preparations
- AB Investment Managers
- Sector
- ALKS Health Care
- AB Finance
- Exchange
- ALKS Nasdaq
- AB Nasdaq
- Market Cap
- ALKS 5.1B
- AB 4.5B
- IPO Year
- ALKS 1991
- AB 1988
- Fundamental
- Price
- ALKS $29.94
- AB $38.81
- Analyst Decision
- ALKS Strong Buy
- AB Hold
- Analyst Count
- ALKS 14
- AB 5
- Target Price
- ALKS $40.64
- AB $39.60
- AVG Volume (30 Days)
- ALKS 1.4M
- AB 166.3K
- Earning Date
- ALKS 10-23-2025
- AB 10-23-2025
- Dividend Yield
- ALKS N/A
- AB 8.39%
- EPS Growth
- ALKS 21.99
- AB 17.05
- EPS
- ALKS 2.08
- AB 3.37
- Revenue
- ALKS $1,505,296,000.00
- AB N/A
- Revenue This Year
- ALKS N/A
- AB N/A
- Revenue Next Year
- ALKS $1.66
- AB $9.45
- P/E Ratio
- ALKS $14.40
- AB $11.54
- Revenue Growth
- ALKS N/A
- AB N/A
- 52 Week Low
- ALKS $25.56
- AB $32.28
- 52 Week High
- ALKS $36.45
- AB $43.30
- Technical
- Relative Strength Index (RSI)
- ALKS 59.07
- AB 36.43
- Support Level
- ALKS $28.77
- AB $38.86
- Resistance Level
- ALKS $31.69
- AB $39.63
- Average True Range (ATR)
- ALKS 0.85
- AB 0.68
- MACD
- ALKS 0.11
- AB -0.08
- Stochastic Oscillator
- ALKS 51.25
- AB 4.85
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
About AB AllianceBernstein Holding L.P.
AllianceBernstein provides investment management services to institutional (41% of assets under management), retail (42%), and private (17%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of June 2025, the company had $829 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (41%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.